Stocksigma LogoStocksigma Logo

Norris Medicines Reports Q2 FY27 Financial Results

Norris Medicines reported revenue from operations of ₹65.65 lakhs for the quarter ended 30th Sep'26, down 67.18% YoY from ₹200.04 lakhs and down 28.97% QoQ

Norris Medicines Reports Q2 FY27 Financial Results

Norris Medicines Ltd · Financial Result · 14 Nov 2026, 11:42 pm

Norris Medicines Reports Q2 FY27 Financial Results Norris Medicines reported revenue from operations of ₹65.65 lakhs for the quarter ended 30th Sep'26, down 67.18% YoY from ₹200.04 lakhs and down 28.97% QoQ from ₹92.49 lakhs. Net loss for the quarter narrowed to ₹36.22 lakhs compared to a loss of ₹71.82 lakhs in 30th Sep'25 and ₹39.68 lakhs in 30th Jun'26. Basic and diluted EPS stood at negative ₹0.36 versus negative ₹0.72 YoY. For the six months ended 30th Sep'26, revenue stood at ₹158.14 lakhs with a net loss of ₹75.90 lakhs.

Original exchange filing (PDF)

More announcements from Norris Medicines Ltd

All Norris Medicines Ltd announcements